Porous Islet Matrix with Nutrient Reservoir Cavities
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing implantable artificial pancreas devices face challenges in maintaining efficient insulin delivery due to nutrient and oxygen depletion within macroencapsulation systems, leading to high islet mortality and limited efficacy.
Innovation Solution
A pancreatic cell receiving matrix with a semi-permeable wall and a porous body containing alternating cavities for pancreatic cells and nutrient/gas reservoirs, ensuring controlled cell distribution and efficient nutrient and gas diffusion.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If macroencapsulation approaches are used to protect islets from immune system attacks, then islet protection from rejection is improved, but nutrient and oxygen diffusion is limited leading to high islet mortality
Solution Approach 1:
The patent employs a porous matrix material with controlled pore size and distribution to enable adequate nutrient and oxygen diffusion while maintaining islet protection. The porous structure allows transport of essential substances throughout the macrocapsule, preventing the diffusion limitations that cause islet mortality in conventional macroencapsulation systems.
Solution Approach 2:
The invention uses composite material structures combining protective encapsulation layers with internally porous support matrices. This composite approach maintains the protective function against immune rejection while the porous composite structure enables sufficient nutrient and gas diffusion to sustain islet viability throughout the macrocapsule volume.
2Reliability
If macroencapsulation approaches are used to protect islets, then immune system protection is improved, but surface biofouling leads to isolation and further limits diffusion
Solution Approach 1:
The patent introduces surface modification layers or intermediary coatings on the macrocapsule exterior that prevent biofouling while maintaining the protective encapsulation function. These intermediary surfaces reduce protein adsorption and cellular adhesion that would otherwise lead to biofouling and isolation of the macrocapsule from the surrounding environment.
3Use of energy by moving object
If vascularization is promoted to supply oxygen to islets, then oxygen supply is improved, but inflammatory molecules are also delivered increasing islet mortality
Solution Approach 1:
The patent segments the transport functions by creating distinct pathways or using selective permeability within the encapsulation system. This segmentation allows oxygen and nutrients to reach islets while blocking or filtering out inflammatory molecules, thus separating the beneficial oxygen supply function from the harmful inflammatory molecule delivery.
Solution Approach 2:
The invention modifies the physical or chemical parameters of the encapsulation material to achieve selective permeability. By changing parameters such as pore size, molecular weight cutoff, or surface charge of the encapsulation material, the system allows passage of oxygen and nutrients while preventing infiltration of larger inflammatory molecules and immune cells.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The matrix design reduces islet mortality and enhances long-term insulin delivery by maintaining optimal nutrient and gas supply to pancreatic cells, minimizing biofouling, and reducing the need for surgical intervention.
Implementation Method 1
a semi-permeable wall delimiting at least part of an internal volume
Implementation Method 2
a porous body, preferably based on at least one polymer, disposed in the internal volume
Implementation Method 3
a porous body, preferably based on at least one polymer, disposed in the internal volume
Data Source
Figure 1~2
Figure 3~4
Figure 5~6A
AI summary
The invention relates to a pancreatic cell receiving matrix (1) comprising a semi-permeable wall (10) and a porous body (12) comprising a first set (120) of cavities (1200) comprising pancreatic cells (13), and a second set (121) of cavities (1210) free of pancreatic cells. The first set (120) of cavities and the second set (121) of cavities are not fluidically connected to one another. The cavity or cavities (1210) left free of cells create paths for the nutrients and gases to diffuse in the matrix (1), and they form a nutrient and gas reserve area in the matrix. The matrix (1) limits and preferably prevents nutrient and gas depletion of the pancreatic cells (13). Their mortality is therefore reduced, allowing better insulin delivery.